rosuvastatin / Generic mfg. |
ACTRN12613000031763: Statin Therapy in Ischemia-Reperfusion Injury during coronary artery bypass grafting. |
|
|
| Not yet recruiting | 4 | 100 | | | South Australian Health and Medical Research Institute, South Australian Health and Medical Research Institute | Post CABG ischemia reperfusion injury (IRI) | | | | |
ACTRN12612000663853: Does Metformin potentiate the effect of Rosuvastatin therapy on biochemical markers in Patients with Polycystic Ovary Syndrome? |
|
|
| Recruiting | 4 | 54 | | | American University of Beirut, American University of Beirut | Polycystic ovary syndrome (PCOS) | | | | |
ACTRN12612000732886: Rosuvastatin versus Protease Inhibitor Switching for Hypercholesterolaemia in HIV-infected Adults. |
|
|
| Recruiting | 4 | 60 | | | St. Vincent's Hospital, Sydney | Hypercholesterolaemia associated with ritonavir-boosted protease inhibitor therapy in of HIV-infected adults | | | | |
ChiCTR-ONC-10001058: Effect of Variant Alleles SLCO1B1 and ABCG2 on Pharmacokinetics of Rosuvastatin in Healthy Volunteers |
|
|
| Completed | 4 | 25 | | collect blood sample | Institute of Clinical Pharmacology, Central South University; Level of the institution:, Self-funding | hyperlipemia | | | | |
ChiCTR-TRC-10001085: Effect of Rosuvastatin on Coronary Atheroma in diffused Coronary Artery Disease |
|
|
| Completed | 4 | 400 | | Rosuvastatin ;Atorvastatin | Second affiliated Hospital of Third Military Medical University; Second affiliated Hospital of Third Military Medical University, Second affiliated Hospital of Third Military Medical University | Diffused Coronary Artery Disease | | | | |
ChiCTR-TRC-13003691: Berberine Chloride Stabilizes Coronary Atherosclerotic Plaques in Clinical Research |
|
|
| Completed | 4 | 120 | | Rosuvastatin+Berberine ;Rosuvastatin | Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine; Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Traditional Chinese Medicine Development of the Three-year Action Plan | coronary heart disease | | | | |
ChiCTR-ONC-14004265: A study to evaluate the effect of intensive statin on subclinical atherosclerosis lesions by intravascular ultrasound |
|
|
| Completed | 4 | 30 | | rosuvastatin 20mg | Cardiovascular Department, Beijing Friendship Hospital; Beijing Friendship Hospital, Capital clinical characteristic applied research | acute coronary syndrome | | | | |
2005-002777-68: The effects of rosuvastatin therapy on glucose metabolism in non-diabetic renal transplant recipients with a focus on insulin sensitivity and pancreatic beta islet cell function |
|
|
| Ongoing | 4 | 20 | Europe | Crestor, Crestor, Crestor | Cardiff and Vale NHS Trust | New-onset diabetes after transplantation | | | | |
2006-006219-56: A multicentre, double-blind, randomised, parallel-group study to evaluate the efficacy, safety and tolerability of ezetimibe/simvastatin 10/40mg, atorvastatin 40mg, and rosuvastatin 10mg to achieve an LDL-C level of <2mmol/l in patients with established CVD or at “high risk” of developing CVD, currently treated with simvastatin 40mg and with a fasting LDL-C 2 mmol/l |
|
|
| Ongoing | 4 | 800 | Europe | Inegy, Crestor, Lipitor, Inegy, Crestor, Lipitor | Merck & Co Inc., | Primary Hypercholesterolaemia | | | | |
2007-000151-33: Does caffeine reduce rosuvastatin-induced protection against ischemia-reperfusion injury? |
|
|
| Ongoing | 4 | 24 | Europe | Rosuvastatin, Crestor, Crestor | UMCN | Rosuvastatin is a proven cholesterol lowering medicine. Apart from it’s cholesterol lowering action, rosuvastatin may also increase tolerance against ischemia-reperfusion injury. We hypothesize that rosuvastatin increases tolerance against ischemia-reperfusion injury by induction of ecto-5’-nucleotidase and thereby increasing adenosine activity.This protective effect of rosuvastatin can be abbrogated by using the adenosine receptor antagonist caffeine. | | | | |
2007-005546-20: Systemic effects of mild renal insufficiency: the relation between forearm blood flow and ADMA. |
|
|
| Ongoing | 4 | 60 | Europe | Rosuvastatine, Olmetec, ZD4522, Crestor, Olmetec, Crestor, Olmetec | academisch ziekenhuis Maastricht | hypertensionmild renal insufficiency | | | | |
2008-005985-30: Is augmentation of PORH by rosuvastatin adenosine-receptor mediated? |
|
|
| Ongoing | 4 | 8 | Europe | caffeine, Crestor, Caffeine, Crestor, Caffeine | Department of Pharmacology-Toxicology | mechanism of influence of statins on human adaptive mechanisms in hypoxic circumstances | | | | |
2007-004894-25: Effect of rosuvastatin on cardiovascular events and mortality after pneumonia |
|
|
| Ongoing | 4 | 670 | Europe | Crestor, Crestor | Karolinska University Hospital Huddinge | Community aquired pneumonia | | | | |
2009-014831-18: Short term statin treatment and endothelial dysfunction due to ischemia and reperfusion injury |
|
|
| Ongoing | 4 | 48 | Europe | rosuvastatin, atorvastatin, rosuvastatin, lipitor, rosuvastatin, lipitor | RUNMC | ischemia and reperfusion injuryendothelial dysfunction | | | | |
2009-011291-29: RACE 3 study: Intensive vs. usual rhythm control for atrial fibrillation. |
|
|
| Ongoing | 4 | 250 | Europe | eplerenone, Spironolactone, atorvastatin, Fluvastatin, Pravastatin, rosuvastatin, Simvastatin, eplerenone, spironolactone, atorvastatin, Fluvastatin, Pravastatin, rosuvastatin, Simvastatin, eplerenone, spironolactone, atorvastatin, Fluvastatin, Pravastatin, rosuvastatin, Simvastatin | Interuniversity Cardiology Institute of the Netherlands (ICIN), Interuniversity Cardiology Institute Netherlands, The Interuniversity Cardiology Institute of the Netherlands (ICIN), Netherlands Heart Foundation (NHS B 2008 035), Working group on Cardiovascular Research, the Netherlands, Sanofi Aventis, Boehringer Ingelheim, Medtronic, Biotronik, St Jude Medical, Boston Scientific, AstraZenenca, Interuniversity Cardiology Institute Netherlands, Working group on Cardiovascular Research, Astra Zeneca, Bayer | atrial fibrillation | | | | |
ChiCTR-IPR-15005761: The effects and mechanism of statins on Glucose metabolism in elderly patients with atherosclerotic cardiovascular disease |
|
|
| Recruiting | 4 | 300 | | Atorvastatin calcium ;Atorvastatin calcium ;Rosuvastatin calcium ;Rosuvastatin calcium ;Pitavastatin calcium ;Pitavastatin calcium | Second Department of Cadre Ward, General Hospital of Jinan Military Region; General Hospital of Jinan Military Region, PLA GeneralLogistics Department of the Ministry of health care of special research projects(14BJZ27) | atherosclerotic cardiovascular disease | | | | |
| Ongoing | 4 | 350 | RoW | Rosuvastatin Krka, Tablet, Rosuvastatin Krka | Icelandic Heart Association, Icelandic Heart Association | Atherosclerosis, Subclinical atherosclerosis of the carotid arteries, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
NCT01816997: The Statins on Glucose Homeostasis in Subjects With Impaired Fasting Glucose |
|
|
| Recruiting | 4 | 160 | RoW | Pravastatin, Pravastatin (Mevalotin), Rosuvastatin, Crestor, Control, placebo | Taipei Veterans General Hospital, Taiwan | Diabetes | 12/17 | 12/22 | | |
ChiCTR-OPC-16009540: Pharmacoeconomics of rosuvastatin in improving intracranial hemodynamics in patients with intracranial atherosclerotic stenosis, a case records based study |
|
|
| Recruiting | 4 | 50 | | intensified dose of rosuvastatin (20 mg/day, 52 weeks) versus standard dose of rosuvastatin (10 mg/day, 52 weeks) | The Second Affiliated hospital of Zhejiang University School of Medicine; The Second Affiliated hospital of Zhejiang University School of Medicine, self-funding | Intracranial atherosclerotic stenosis | | | | |
ChiCTR-IPR-15007184: Effect of Rosuvastatin Therapy on HDL2 Level andAntiatherosclerotic Reverse Cholesterol Transport Process in Chinses CAD patients with hyperlipidemia |
|
|
| Not yet recruiting | 4 | 300 | | rosuvastatin | Daping Hospital, Third Military Medical University; Daping Hospital, Externally Sponsored Scientific Research | Coronary heart disease (CHD).hyperlipidemia | | | | |
ChiCTR-IPR-17011827: Effects of rosuvastatin combined with garlic extract on patients of pulmonary hypertension: A random, controlled trial. |
|
|
| Recruiting | 4 | 120 | | rosuvastatin oral based on routine treatment ;garlic extract oral based on routine treatment ;rosuvastatin combined with garlic extract oral based on routine treatment | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; Key Laboratory of Pulmonary Diseases of Ministry of Health, Tongji Medical College, Huazhong University of Science and Technology, Natural Science Foundation of China; State key research and development plan | pulmonary hypertension | | | | |
| Not yet recruiting | 4 | 44 | Europe | Rosuvastatin, Film-coated tablet, Crestor | Centro Hospitalar e Universitário de Coimbra, E.P.E., Astrazeneca-Produtos Farmacêuticos, Lda | Atherosclerosis, namely in the aorta, carotid and coronary arteries, Cardiovascular disease, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
ChiCTR1900027173: Therapeutic effect of rosuvastatin on metabolic syndrome in patients with bipolar disorder |
|
|
| Recruiting | 4 | 120 | | Atorvastatin and Behavioral Interventions ;Behavioral Interventions | Hefei Fourth People's Hospital; Hefei Fourth People's Hospital, Pathogenesis of bipolar disorder based on singlecell multi-omics, imaging and cognitive function | Bipolar disorder | | | | |
ASTRO-CHF, NCT05072054: Comparison of Effects of Atorvastatin Versus Rosuvastatin on Cardiac Function in Heart Failure Patients |
|
|
| Recruiting | 4 | 80 | RoW | Atorvastatin Oral Tablet, Rosuvastatin Oral Tablet | Postgraduate Institute of Medical Education and Research, Indian Council of Medical Research | Heart Failure With Reduced Ejection Fraction | 06/22 | 08/22 | | |
NCT03988101: Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event |
|
|
| Recruiting | 4 | 100 | RoW | Rosuvastatin 20mg, Control | Yonsei University | Venous Thromboembolism, Dyslipidemias | 11/22 | 11/22 | | |
| Active, not recruiting | 4 | 25 | US | Rosuvastatin 20mg, Placebo | Minneapolis Heart Institute Foundation | Cardiovascular Risk Factor, Cardiovascular Diseases, Adverse Effect | 12/22 | 12/22 | | |
ChiCTR2100043102: Efficacy and safety of rosuvastatin combined with Shouhui Tongbian capsule in the treatment of dyslipidemia: a prospective, single-center, open, randomized controlled study |
|
|
| Recruiting | 4 | 40 | | Rosuvastatin calcium tablet + Shouhui tongbei capsule ;Rosuvastatin calcium tablet | Beijing Friendship Hospital Affiliated to Capital Medical University; Beijing Friendship Hospital Affiliated to Capital Medical University, Lunan Houpu Pharmaceutical Co., Ltd | Dyslipidemia | | | | |
NCT06273215: Evaluation of the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Diabetic Patients |
|
|
| Recruiting | 4 | 48 | RoW | The combinations of 10 µg midazolam, 375 µg dabigatran etexilate, 10 µg pitavastatin, 50 µg rosuvastatin, and 100 µg atorvastatin were administered to diabetic patients on an empty stomach. | Peking University Third Hospital | Diabetes | 12/25 | 12/25 | | |
ChiCTR2200057751: Evaluation of the efficacy of rosuvastatin combined with cardiac oral solution in the treatment of patients with dyslipidemia with elevated lipoprotein (a) |
|
|
| Recruiting | 4 | 100 | | On the basis of rosuvastatin, Xintong oral solution was combined ;Suvastatin calcium tablets | Liaoning Provincial Health Industry Group Ben'gang General Hospital; Liaoning Provincial Health Industry Group Ben'gang General Hospital, Lunanbet Pharmaceuticals Ltd. | Dyslipidemia with elevated lipoprotein (a) | | | | |
ChiCTR2200057772: Short-term evaluation of modified, low-dose PCSK9 inhibitors combined with statins in the treatment of acute coronary syndrome dyslipidemia in Chinese |
|
|
| Not yet recruiting | 4 | 100 | | receive medium-dose statin daily(atorvastatin 20mg qn or rosuvastatin 10mg qn) ;receive medium-dose statin daily(atorvastatin 20mg qn or rosuvastatin 10mg qn)+once a month, subcutaneous injection of 1 injection of PCSK9 inhibitor each time ;receive medium-dose statin daily(atorvastatin 20mg qn or rosuvastatin 10mg qn)+twice a month, subcutaneous injection of 1 injection of PCSK9 inhibitor each time | The First Affiliated Hospital of Nanjing Medical University; Jiangsu Provincial People's Hospital, Self-funded | acute coronary syndrome | | | | |
| Completed | 4 | 22 | US | moderate- or high-intensity statin/ rosuvastatin, Crestor | Wake Forest University Health Sciences | Lipid Disorder | 06/23 | 07/23 | | |
ChiCTR2200062305: Mr-VPD evaluation of PCSK9i in patients with intracranial atherosclerotic stenosis |
|
|
| Recruiting | 4 | 100 | | PCSK9iatorvastatin calcium 20mg/ rosuvastatin calcium 10mg; atorvastatin calcium 20mg/ rosuvastatin calcium 10mg | The Second Affiliated Hospital of the Army Medical University; The Second Affiliated Hospital of the Army Medical University, The patient's normal medical treatment process, examination fees and drug costs shall be borne by themself. | Cerebral vascular disease | | | | |
NCT06053983: Comparison Between Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients With Acute Coronary Syndrome |
|
|
| Completed | 4 | 126 | RoW | Turbox CRP kit, rosuvastatin 20 mg,, atorvastatin 40 mg | Rawalpindi Medical College | Mi Q Wave | 08/23 | 08/23 | | |
| Active, not recruiting | 4 | 2476 | US | High dose potent statin, atorvastatin or rosuvastatin, ACE-I (lisinopril) or ARB (losartan), ACE-I or ARB, Aspirin, Lifestyle Counseling, PACE Lifestyle Intervention, Quality of Life Questionnaires, QOL | University of Florida, United States Department of Defense | Coronary Artery Disease | 09/24 | 12/24 | | |
| Recruiting | 4 | 1000 | RoW | protective ventilation, prone position ventilation, glucocorticoid therapy, Dexamethasone, Hydrocortisone, restrictive fluid resuscitation, Thymosin Alpha, Muscle relaxant therapy, Vecuronium Bromide, Succinylcholine, Integrated Chinese and Western Medicine Treatment, statin therapy, Simvastatin, Rosuvastatin, anti-infective treatment, Extracorporeal Membrane Oxygenation(ECMO), stem cell therapy, Sedative analgesia/muscle relaxant therapy, Propofol, midazolam, dexmedetomidine, inotropes therapy, Dopamine, Olprinone, Levosimendan, Vasoactive drug therapy, Norepinephrine, epinephrine, metaraminol, isoproterenol | Second Affiliated Hospital, School of Medicine, Zhejiang University, Renmin Hospital of Wuhan University, The Second Affiliated Hospital of Harbin Medical University, West China Hospital, The First Affiliated Hospital of Zhengzhou University, Peking Union Medical College Hospital, Wuhan Union Hospital, China, Fudan University, Guangdong Provincial People's Hospital, Ningbo No. 1 Hospital, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University | Acute Respiratory Distress Syndrome | 10/23 | 12/23 | | |
NCT06153433: Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia |
|
|
| Recruiting | 4 | 112 | RoW | Rosuvastatin Immediate-Release Tablet (IRT) 10mg, Rosuvastatin orally disintegrating tablet (SUVARO®ODT) 10mg | Yonsei University | Dyslipidemia | 07/24 | 08/24 | | |
EVALUATE-STEMI, NCT05613426: Effect of Very Early and Rapid Lowering Cholesterol With Evolocumab on Left Ventricular Remodeling in Patients With Anterior STEMI Undergoing Primary PCI |
|
|
| Recruiting | 4 | 330 | RoW | Rosuvastatin 20 mg, Evolocumab 140 mg/1 ml Subcutaneous Solution [REPATHA] | Henan Institute of Cardiovascular Epidemiology | ST Elevation Myocardial Infarction (STEMI) | 12/23 | 12/24 | | |
ChiCTR2200055718: Effects of PCSK9 inhibitor therapy on fractional flow reserve in coronary borderline lesions |
|
|
| Recruiting | 4 | 170 | | On the basis of conventional statin therapy, use Repatha subcutaneous injection to treat 1 vial of Q2W ;Atorvastatin 20mg/day or rosuvastatin 10mg/day | Tianjin Medical University General Hospital; Tianjin Medical University General Hospital, Suzhou Industrial Park Xinxin Cardiovascular Health Foundation | Coronary atherosclerosis | | | | |
EItoCVP, NCT06338293: Effects of Inclisiran Combined With Statins on the Morphology of Coronary Vulnerable Plaques |
|
|
| Not yet recruiting | 4 | 40 | NA | Inclisiran sodium, Rosuvastatin | Nanjing First Hospital, Nanjing Medical University | Coronary Artery Disease | 12/24 | 05/25 | | |
PREVESTATGx, NCT06262685: Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins |
|
|
| Not yet recruiting | 4 | 216 | Europe | Preemptive pharmacogenetic atorvastatin dose based on CPIC guidelines, Preemptive pharmacogenetic simvastatin dose based on CPIC guidelines, Preemptive pharmacogenetic pitavastatin dose based on CPIC guidelines, Preemptive pharmacogenetic rosuvastatin dose based on CPIC guidelines, Preemptive pharmacogenetic pravastatin dose based on CPIC guidelines, Preemptive pharmacogenetic lovastatin dose based on CPIC guidelines, Preemptive pharmacogenetic fluvastatin dose based on CPIC guidelines, Standard of Care (SoC) dosing of atorvastatin, Standard of Care (SoC) dosing of simvastatin, Standard of Care (SoC) dosing of pitavastatin, Standard of Care (SoC) dosing of rosuvastatin, Standard of Care (SoC) dosing of prasavastatin, Standard of Care (SoC) dosing of lovastatin, Standard of Care (SoC) dosing of fluvastatin | Instituto de Investigación Hospital Universitario La Paz, Instituto de Salud Carlos III | Cardiovascular Diseases, Dyslipidemias, Statin Adverse Reaction, Pharmacogenic Myopathy | 02/25 | 03/25 | | |
| Active, not recruiting | 4 | 62 | US | Rosuvastatin, Crestor, Placebo | Sony Tuteja | Healthy Volunteers | 06/24 | 06/24 | | |
NCT05747768: A Clinical Study to Evaluate the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Healthy Volunteers and Renal Impairment Patients |
|
|
| Recruiting | 4 | 60 | RoW | Midazolam, dabigatran etexilate, pitavastatin, rosuvastatin and atorvastatin | Peking University Third Hospital | Chronic Kidney Disease | 06/24 | 12/24 | | |
ChiCTR2300069104: Efficacy and safety analysis of PCSK9 inhibitors in patients with acute ischemic stroke caused by symptomatic intracranial atherosclerotic stenosis |
|
|
| Not yet recruiting | 4 | 178 | | PCSK9i + atorvastatin calcium 20mg/ rosuvastatin calcium 10mg ;atorvastatin calcium 40mg/ rosuvastatin calcium 20mg | The Second Affiliated Hospital of Dalian Medical University; The Second Affiliated Hospital of Dalian Medical University, self funding | Ischemic cerebrovascular disease | | | | |
PROACT 2, NCT05850091: Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine |
|
|
| Recruiting | 4 | 200 | US | Rosuvastatin, Colchicine, Placebo | Massachusetts General Hospital, National Heart, Lung, and Blood Institute (NHLBI) | Coronary Artery Disease | 07/26 | 07/27 | | |
| Completed | 3/4 | 12705 | Europe, RoW | Crestor, Atacand Plus, Tablet, Crestor | Population Health Research Institute, McMaster University/Hamilton Health Sciences, Population Health Research Institute (PHRI), McMaster University/Hamilton Health Sciences, University of Leicester, Population Health Research Institute, | Childbirth | | | | |
2009-012850-19: Statins IN TREATMENT OF ACUTE coronary syndrome. COMPARISON OF EFFICACY BETWEEN Atorvastatin and Rosuvastatin IN PATIENTS UNDERGO A PTCA THROUGH THE MONITORING OF C REACTIVE PROTEIN |
|
|
| Ongoing | 3 | 120 | Europe | Tablet | AZIENDA SANITARIA LOCALE DI BARI | Patients with Acute coronary syndrome without up-leveling of ST line. | | | | |
2020-001319-26: Clinical trial to assess the prognostic repercussions of rosuvastatin treatment in patients discharged after hospitalization for COVID-19 Positive. Ensayo clÃnico para evaluar las repercusiones en el pronóstico del tratamiento con rosuvastatina en pacientes dados de alta tras hospitalización por COVID-19 Positivo. |
|
|
| Ongoing | 3 | 1080 | Europe | Tablet | Instituto de Investigación Sanitaria Fundación Jiménez DÃaz, Fundación Jiménez DÃaz | COVID respiratory infection Infección respiratoria por COVID, Respiratory infection by Coronavirus Infección respiratoria por Coronavirus, Diseases [C] - Virus Diseases [C02] | | | | |
2019-004208-37: Statins for treating ulcerative colitis through GI microbiome Statines voor de behandeling van ulceratieve colitis door middel van GI-microbioom |
|
|
| Not yet recruiting | 3 | 400 | Europe | rosuvastatin, Tablet, Rosuvastatine EG | UZ Leuven, Fonds Wetenschappelijk Onderzoek - Vlaanderen (FWO), Vlaamse Instituut Biotechnologie | There are two population groups, 20 healthy volunteers and at least 165 individuals diagnosed with IBD. Either with remission to mild/moderate active ulcerative colitis or remission to mild Crohn's disease., A bowel disease that are characterized by inflammation with ulcer formation in the lining of large intestine (UC) and/or rest of intestines (CD). Characterized by diarrhea and abdominal cramps., Diseases [C] - Digestive System Diseases [C06] | | | | |
2021-005602-10: Study which will investigate, if the treatment with Inclisiran, Bempedoic acid and monoclonal antibodies Alirocumab or Evolocumab has other than lipid-lowering effects such as change in platelet activity and inflammation markers. |
|
|
| Not yet recruiting | 3 | 60 | Europe | Inclisiran, Nilemdo, Repatha, Rosuvastatin, Atorvastatin, Solution for injection in pre-filled syringe, Film-coated tablet, Leqvio, Nilemdo, Repatha, Rosuvastatin, Atorvastatin | Verein zur Förderung der Forschung auf dem Gebiet der Arteriosklerose, Thrombose und vaskulären Biologie (ATVB), Verein zur Fördferung der Forschung auf dem Gebiet der Arteriosklerose, Thrombose und vaskulären Biologie (ATVB) | platelet activity and inflammation markers in patients with coronary artery disease, platelet activity and inflammation markers in patients with coronary artery disease, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
STAR, NCT03037372: Statin Adjunct Therapy Among ART-treated Adults in Sub-Saharan Africa: Atorvastatin and Rosuvastatin Equivalence Trial |
|
|
| Not yet recruiting | 3 | 320 | NA | ART, Atorvastatin, Atovastatin adjunct therapy, ART, Rosuvastatin, Rosuvastatin adjunct therapy, ART, No statin, No statin adjunct therapy, Healthy-HIV-negative, HIV-negative controls | Makerere University, University of Oxford, Case Western Reserve University | HIV Infection | 06/22 | 12/22 | | |
| Completed | 3 | 1196 | US | 5 mg rosuvastatin calcium with a Web App (combination product), Crestor 5 mg | AstraZeneca, Concentrics Research LLC, Concentrics Research - STATKING JV, Idea Evolver, The Cleveland Clinic | High Cholesterol | 03/23 | 03/23 | | |
NCT03527069: Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment |
|
|
| Recruiting | 3 | 298 | RoW | Cipros 10 association, EMS association, Crestor 10 mg, Rosuvastatin 10 mg | EMS | Hypertriglyceridemia, Dyslipidemia | 06/24 | 02/25 | | |
| Recruiting | 3 | 120 | Europe | Rosuvastatin 40mg, Ezetimib 10mg | Bjarne Linde Noergaard | Coronary Artery Disease | 08/23 | 08/23 | | |
NCT05338723: Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients |
|
|
| Completed | 3 | 50 | RoW | Rosuvastatin 20mg | Tanta University | Chemotherapy-induced Cardiotoxicity, Breast Cancer | 09/23 | 09/23 | | |
NCT03540355: Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment |
|
|
| Recruiting | 3 | 312 | RoW | Cipros 20 association, EMS Association, Crestor 20 mg, Rosuvastatin 20 mg | EMS | Dyslipidemias | 11/23 | 02/24 | | |
NCT05731596: Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic Steatohepatitis |
|
|
| Not yet recruiting | 3 | 46 | NA | Rosuvastatin 20 Mg Oral Tablet, Coenzyme Q10 100 MG Oral Capsule | Tanta University | Nonalcoholic Steatohepatitis | 02/24 | 04/24 | | |
NCT06358313: Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Minor Stroke or TIA |
|
|
| Recruiting | 3 | 600 | RoW | Atorvastatin 40mg, group A, Rosuvastatin 20mg, group B | Kafrelsheikh University | Ischemic Stroke | 04/25 | 05/25 | | |
NCT06360120: Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke |
|
|
| Recruiting | 3 | 600 | RoW | Atorvastatin 40 Mg Oral Tablet, group A, Rosuvastatin 20mg, group B | Kafrelsheikh University | Ischemic Stroke | 04/25 | 05/25 | | |
ChiCTR2200066956: Effect of intensive statin therapy on ventricular remodeling and cardiac function after PPCI in older STEMI patients |
|
|
| Recruiting | 3 | 100 | | rosuvastatin, 20mg/d ;rosuvastatin, 10mg/d | QingPu Branch of Zhongshan Hospital, Fudan University; QingPu Branch of Zhongshan Hospital, Fudan University, Shanghai Municipal Health Commission | STEMI | | | | |
NCT04603508: Efficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia |
|
|
| Not yet recruiting | 3 | 240 | NA | BERLIM 25/10 association, EMPAGLIFLOZIN, ROSUVASTATIN CALCIUM, BERLIM 25/10 ASSOCIATION PLACEBO, EMPAGLIFLOZIN PLACEBO, ROSUVASTATIN CALCIUM PLACEBO | EMS | Type 2 Diabetes Mellitus, Dyslipidemia | 04/25 | 08/25 | | |
NCT04602754: Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia. |
|
|
| Recruiting | 3 | 228 | RoW | BERLIM 25/20 ASSOCIATION, EMPAGLIFLOZIN PLACEBO, ROSUVASTATIN CALCIUM PLACEBO, EMPAGLIFLOZIN, ROSUVASTATIN CALCIUM, BERLIM 25/20 ASSOCIATION PLACEBO | EMS | Dyslipidemia Associated With Type II Diabetes Mellitus | 04/25 | 08/25 | | |
| Recruiting | 3 | 2700 | Europe, Canada | Rosuvastatin Calcium, Rosuvastatin, Placebo Oral Tablet, Placebo | Ottawa Hospital Research Institute | Venous Thromboembolism, Blood Clot, Post Thrombotic Syndrome | 01/26 | 01/27 | | |
ACTRN12616001544460: Effect of Sublingual (under the tongue) Rosuvastatin/Crestor (cholesterol/statin medication) in reducing the side effects experienced in subjects with high cholesterol & a history of cardiovascular disease (heart attack, coronary artery disease) with a known statin intolerance. |
|
|
| Recruiting | 2/3 | 20 | | | Dr Gregory Szto , AusIndustry | coronary artery disease, Hyperlipidaemia, Diabetes, peripheral vascular disease | | | | |
NCT03720067: Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension |
|
|
| Recruiting | 2/3 | 80 | RoW | Propranolol, Carvedilol, Rosuvastatin, Placebo | Universidade Federal do Rio de Janeiro | Cirrhosis, Portal Hypertension, Variceal Hemorrhage | 12/20 | 12/22 | | |
| Not yet recruiting | 2/3 | 2700 | Europe | Rosuvastatin calcium, Tablet | Ottawa Hospital Research Institute, The Canadian Institutes of Health Research (CIHR) | Patients who are verified to have had deep venous thrombosis and/orpulmonary embolism, Diseases [C] - Blood and lymphatic diseases [C15] | | | | |
ReMiDy, NCT04883840: Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis |
|
|
| Recruiting | 2/3 | 220 | Europe | Rosuvastatin 10mg | Universitaire Ziekenhuizen KU Leuven, Vlaams Instituut Biotechnologie (VIB) | Ulcerative Colitis | 11/23 | 12/23 | | |
| Recruiting | 2/3 | 270 | RoW | Dapagliflozin 10mg Tab, FORXIGA, Statins (Cardiovascular Agents), Atorvastatin, Pravastatin, Rosuvastatin, Platelet Antiaggregant, Clopidogrel, Acetylsalicylic acid, Antidiabetic, Sulfonylureas, Meglitinides, Biguanides, Thiazolidinediones, α-Glucosidase inhibitors, Inhibitors of dipeptidyl peptidase 4, Cycloset, Insulin glargine, Insulin lispro, Isophane insulin | Jaime Daniel Mondragon, Hospital General León, Hospital General de Zona IMSS N0. 21, University Medical Center Groningen | Stroke, Ischemic, Mild Cognitive Impairment, Dementia, Vascular, Metabolic Syndrome | 12/24 | 07/25 | | |
2009-016737-95: ROSuvastatin Pretreatment during Carotid Artery Stenting Pretrattamento con Rosuvastatina durante Angioplastica Carotidea |
|
|
| Ongoing | 2 | 130 | Europe | Film-coated tablet | AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA, DIPARTIMENTO CARDIOTORACICO E VASCOLARE UNIVERSITA' DI PISA | Asymptomatic carotid stenosis >80% in patients with baseline LDL cholesterol >120 mg/dL. Stenosi carotidea >80% asintomatica in pazienti con colesterolemia LDL >120 mg/dL., Carotid stenosis Stenosi carotidea, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
| Ongoing | 2 | 100 | Europe | acetylcysteine, rosuvastatin, | AstraZeneca | Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease state characterized by airflow limitation that is not fully reverible. The airflow limitation is usually progressive and associated with an abnormal inflammatory response of the lungs to noxious particles or gases, primarily caused by cigarette smoking. | | | | |
2012-002877-71: cGMP Enhancing Therapeutic Strategy for HFpEF: The cGETS Study An interventional, single blind, multicentre study. cGMP verhogende strategieën bij HFpEF: De cGETS Studie. Een interventionele, enkelblinde, multicentre studie. |
|
|
| Ongoing | 2 | 25 | Europe | Tritace, Tablet, Film-coated tablet, Capsule, Januvia, Cialis, Lipitor, Zestril, Crestor, Zocor, Coversyl, Tritace, Atacand, Nebilet | European Commission FP7 Health 2010, European Commission FP7 Health 2010 | HFpEF patients over 18 years old and concomitant arterial hypertension, overweight or obesity and pulmonary hypertension. Patiënten met HFpEF die ouder zijn dan 18 jaar en tevens lijden aan arteriële hypertensie, overgewicht of obesitas en pulmonale hypertensie., Heart Failure with preserved Ejection Fraction in combination with a high blood pressure, high pulmonary blood pressure and overweight or obesity. Hartfalen met een bewaarde ejectiefractie met daarnaast een hoge bloeddruk, hoge longbloeddruk en overgewicht of zwaarlijvigheid., Diseases [C] - Cardiovascular Diseases [C14] | | | | |
| Not yet recruiting | 2 | 154 | RoW | Rosuvastatin 10mg, Crestor, Rifampicin, Isoniazid, Pyrazinamide, Ethambutol | National University Hospital, Singapore | Pulmonary Tuberculosis | 03/21 | 03/21 | | |
NCT04817904: Evaluation of the Effect of Rosuvastatin on Cisplatin-induced Nephrotoxicity and Ototoxicity |
|
|
| Recruiting | 2 | 65 | RoW | Rosuvastatin 10mg | Cairo University, German University in Cairo | Cisplatin Adverse Reaction | 08/21 | 08/21 | | |
NCT04303806: Effect of Rosuvastatin on the Clinical Features of Preeclampsia |
|
|
| Not yet recruiting | 2 | 80 | NA | rosuvastatin | Assiut University | Preeclampsia | 10/22 | 12/23 | | |
| Active, not recruiting | 2 | 8 | Canada, US | Rosuvastatin Calcium, Placebo Oral Tablet, Coenzyme Q10, Calcium Carbonate, Vitamin D | Dr. B. Catharine. Craven, The Craig H. Neilsen Foundation, Toronto Rehabilitation Institute, University Health Network, Toronto, University of Miami, Rick Hansen Institute | Spinal Cord Injuries, Osteoporosis, Metabolic Syndrome | 12/22 | 12/22 | | |
NCT05895123: Comparison Between the Effects of High Doses Statin on Ventricular Remodeling in STEMI Patients |
|
|
| Completed | 2 | 80 | RoW | Rosuvastatin 20 mg ,40 mg, cholerose, Atorvastatin 40mg,80mg, ator | Damanhour University, Alexandria University | ST-segment Elevation Myocardial Infarction | 03/23 | 04/23 | | |
NCT04491643: Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma |
|
|
| Recruiting | 2 | 48 | RoW | Megestrol Acetate, Rosuvastatin | Fudan University | Endometrial Carcinoma Stage I | 08/25 | 08/25 | | |
NCT03532139: Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study) |
|
|
| Active, not recruiting | 2 | 24 | US | Enoxaparin, Enoxaparin + Rosuvastatin, Thromboprophylaxis | Beth Israel Deaconess Medical Center, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) | Ovarian Cancer | 12/23 | 05/24 | | |
SATBRAD, NCT04824911: Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease |
|
|
| Recruiting | 2 | 424 | RoW | Clopidogrel, Aspirin, Atorvastatin, Rosuvastatin | Chang Gung Memorial Hospital | Acute Stroke, Dual Antiplatelet Therapy, Statin | 02/24 | 07/26 | | |
NCT06102863: Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia |
|
|
| Recruiting | 2 | 38 | RoW | statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day); | Peking University People's Hospital | Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I | 12/24 | 02/25 | | |
LCN RESCU, NCT05832229: Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States |
|
|
| Recruiting | 2 | 256 | US | Rosuvastatin, Rosuvastatin 20 mg, Rosuvastatin 10 mg | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), The Cleveland Clinic, Columbia University, Weill Medical College of Cornell University, Duke University, Mayo Clinic, University of Miami, University of Michigan, University of California, San Diego, University of California, San Francisco, LAC+USC Medical Center, Virginia Commonwealth University, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Cancer Institute (NCI), University of Southern California | Cirrhosis, Cirrhosis, Liver, Cirrhosis Early, Cirrhosis Due to Hepatitis B, Cirrhosis Advanced, Cirrhosis Infectious, Cirrhosis Alcoholic, Cirrhosis, Biliary, Cirrhosis Cryptogenic, Cirrhosis Due to Hepatitis C, Cirrhosis Due to Primary Sclerosing Cholangitis | 11/26 | 11/26 | | |
NCT05483010: Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS) |
|
|
| Recruiting | 2 | 16 | US | Atorvastatin, Lipitor, Rosuvastatin, Crestor | Washington University School of Medicine | Clonal Cytopenia of Undetermined Significance, Myelodysplastic Syndromes | 05/27 | 05/27 | | |
NCT06048588: YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis |
|
|
| Recruiting | 1/2 | 130 | RoW | YN001, Placebo for YN001, Placebo, rosuvastatin calcium tablets, Crestor® | Beijing Inno Medicine Co., Ltd. | Atherosclerotic Cardiovascular Disease | 10/24 | 11/24 | | |
NCT04833764: Mechanisms of Deep Vein Thrombosis (DVT) and Vein Wall Fibrosis |
|
|
| Recruiting | 1/2 | 30 | US | Rosuvastatin | Khanh Nguyen | Post-thrombotic Syndrome, Deep Vein Thrombosis Leg | 06/25 | 06/25 | | |
ACTRN12621000785808p: A Phase 1 Study to Evaluate the Effect of Itraconazole on the
Pharmacokinetics of GS-5718 and to Evaluate the Effect of
GS-5718 on the Pharmacokinetics of Rosuvastatin in Healthy
Subjects |
|
|
| Not yet recruiting | 1 | 32 | | | Gilead Sciences, Gilead Sciences | Inflammatory Diseases | | | | |
ACTRN12621000785808: A Phase 1 Study to Evaluate the Effect of Itraconazole on the
Pharmacokinetics of GS-5718 and to Evaluate the Effect of
GS-5718 on the Pharmacokinetics of Rosuvastatin in Healthy
Subjects |
|
|
| Recruiting | 1 | 32 | | | Gilead Sciences, Gilead Sciences | Inflammatory Diseases | | | | |
ChiCTR-IPR-15007014: Effect of Rosuvastatin (10mg/d) treatment of Nonalcoholic fatty liver disease (NAFLD) patients with Metabolic Syndrome (MS) but without diabetes evaluated by 1H-MRS: Exploratory study |
|
|
| Recruiting | 1 | 20 | | rosuvastatin (10mg/d) * 52 weeks | Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences; Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, AstraZeneca Investment (China) Co., Ltd | Nonalcoholic fatty liver disease(NAFLD) | | | | |
| Completed | 1 | 48 | | oral ingestion of a single dose of rosuvastatin tablets (5mg) ;oral ingestion of a single dose of rosuvastatin tablets (10mg) ;oral ingestion of a single dose of rosuvastatin tablets (20mg) ;oral ingestion of a single dose of rosuvastatin tablets (10mg) | The Second Affiliated Hospital, School of Medicine, Zhejiang University; The Second Affiliated Hospital, School of Medicine,Zhejiang University, Zhejiang Yongning Pharmaceutical Company | Hypercholesterolemia (phase II); Phase I pharmacokinetics study(not involving disease) | | | | |
ChiCTR-TTRCC-12002290: Investigations on relations between SNPs in statin-related transporters and metabolizing enzymes and pharmacokinetics of fluvastatin, simvastatin, rosuvastatin and pitavastatin |
|
|
| Completed | 1 | 64 | | Retrospective analysis of pharmacokinetics data and collect 5ml blood for genotying ;Retrospective analysis of pharmacokinetics data and collect 5ml blood for genotying ;Retrospective analysis of pharmacokinetics data and collect 5ml blood for genotying ;Retrospective analysis of pharmacokinetics data and collect 5ml blood for genotying | The 2nd Affiliated Hospital, School of Medicine, Zhejiang University; The Second Affiliated Hospital, School of Medicine,Zhejiang University, Division of Clinical Pharmacology, The 2nd Affiliated Hospital, School of Medicine, Zhejiang University | not disease-related | | | | |
ChiCTR-RCH-12002706: Role of BCRP 421C>A and 34G>A polymorphisms on rosuvastatin pharmacokinetics in healthy Chinese males and its molecular mechanism |
|
|
| Completed | 1 | 72 | | Nil | Institute of Clinical Pharmacology, Central South University; Level of the institution:, National Natural Science Foundation of China | Hyperlipidemia | | | | |
ChiCTR-RCH-12002823: analysis ABCG2 gene methylation and exporing its effects on pharmacokinetics of rosuvastatin |
|
|
| Completed | 1 | 24 | | rosuvastatin | Institute of Clinical Pharmacology, Central South University; Institute of Clinical Pharmacology, Central South University, National Natural Science Foundation of China | Hyperlipidemia | | | | |
ChiCTR-ONC-13003007: Interactions of herbs with statin drugs and potential mediation by drug transporters |
|
|
| Not yet recruiting | 1 | 36 | | Simvastatin 20mg/ Rosuvastatin 10mg for 3 days and Green Tea Extract 400mg for 15 days | Chinese University of Hong Kong; Level of the institution:, Chinese University of Hong Kong | Healthy Volunteers | | | | |
NCT02592317: A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer |
|
|
| Recruiting | 1 | 20 | Europe, RoW | JNJ 56021927, Drug Cocktail, Pioglitazone, Rosuvastatin | Aragon Pharmaceuticals, Inc. | Prostatic Neoplasms, Castration-Resistant | 11/16 | 12/24 | | |
ChiCTR1900021628: A Drug-drug Interaction(DDI) Study Of Yimitasvir And Rosuvastatin In Healthy Male Subjects |
|
|
| Not yet recruiting | 1 | 14 | | Yimitasvir100mg+Rosuvastatin10mg | the First Hospital of Jilin University; the First Hospital of Jilin University, self-funding | chronic hepatitis C | | | | |
NCT03864042: Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors |
|
|
| Active, not recruiting | 1 | 56 | Europe, Canada, US | losartan, dextromethorphan, caffeine, omeprazole, midazolam, rosuvastatin, bupropion immediate release (IR), encorafenib, binimetinib, modafinil | Pfizer, Pierre Fabre Laboratories | Advanced Solid Tumors, Metastatic Melanoma | 07/22 | 06/23 | | |
NCT05594615: Drug-Drug Interaction Study Between EDP-235, Midazolam, Caffeine and Rosuvastatin in Healthy Subjects |
|
|
| Completed | 1 | 24 | US | EDP-235, Midazolam, Rosuvastatin, Caffeine | Enanta Pharmaceuticals, Inc | COVID-19 | 11/22 | 11/22 | | |
NCT05389722: A Study to Assess the Drug Levels of CC-92480 After Coadministration With Rifampin and Itraconazole, and the Drug Levels of Digoxin and Rosuvastatin After Coadministration With CC-92480 in Healthy Participants |
|
|
| Completed | 1 | 24 | US | CC-92480, BMS-986348, Rifampin, Itraconazole, Digoxin, Rosuvastatin | Bristol-Myers Squibb | Healthy Volunteers | 11/22 | 11/22 | | |
NCT04887194: PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates |
|
|
| Completed | 1 | 40 | US | Sitravatinib, MGCD516, Warfarin, Coumadin, Dextromethorphan, Robitussin, Midazolam, Versed, Digoxin, LANOXICAPS, Rosuvastatin, Crestor, Nivolumab, OPDIVO | Mirati Therapeutics Inc. | Advanced Solid Tumor | 12/22 | 12/22 | | |
| Recruiting | 1 | 10 | Europe | Placebo, Ticagrelor, Rosuvastatin | Helsinki University Central Hospital, University of Helsinki | Pharmacokinetics | 12/22 | 12/22 | | |
NCT05652660: A Study to Understand the Effect of a Study Medicine Called ARV-471 on Rosuvastatin in Healthy Adults |
|
|
| Completed | 1 | 12 | US | ARV-471, PF-07850327, Rosuvastatin, CRESTOR® | Pfizer, Arvinas Estrogen Receptor, Inc. | Healthy | 03/23 | 03/23 | | |
NCT05708573: Potential Drug Interaction Between ALXN2040 and Rosuvastatin |
|
|
| Completed | 1 | 20 | US | Rosuvastatin, ALXN2040 | Alexion | Healthy Participants | 03/23 | 04/23 | | |